221 related articles for article (PubMed ID: 1279241)
1. [Clinical application of anticancer cytokines].
Watanabe N
Nihon Rinsho; 1992 Aug; 50(8):1973-7. PubMed ID: 1279241
[TBL] [Abstract][Full Text] [Related]
2. Cytokines.
Holmlund JT
Cancer Chemother Biol Response Modif; 1993; 14():150-206. PubMed ID: 7508728
[No Abstract] [Full Text] [Related]
3. Cytokines and immunological monitoring.
Sosman JA; Sawhaney A
Cancer Chemother Biol Response Modif; 1997; 17():217-86. PubMed ID: 9551216
[No Abstract] [Full Text] [Related]
4. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
5. [Cytokines in tumor therapy].
Lindemann A; Oster W; Herrmann F; Mertelsmann R
Arzneimittelforschung; 1988 Mar; 38(3A):466-9. PubMed ID: 2456072
[TBL] [Abstract][Full Text] [Related]
6. [Biological response modifiers and cancer treatment].
Urushizaki I
Gan No Rinsho; 1989 Jan; Spec No():25-33. PubMed ID: 2464707
[No Abstract] [Full Text] [Related]
7. Lymphokines and cytokines.
Wagstaff J; Melief KJ
Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
[TBL] [Abstract][Full Text] [Related]
8. Lymphokines and cytokines.
Wagstaff J; Melief K
Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
[No Abstract] [Full Text] [Related]
9. Lymphokines and cytokines.
Wagstaff J
Cancer Chemother Biol Response Modif; 1990; 11():204-34. PubMed ID: 1699586
[No Abstract] [Full Text] [Related]
10. [Cutaneous side effects of clinically relevant cytokine therapies].
Trefzer U; Hofmann M; Sterry W
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1782-7. PubMed ID: 12934174
[No Abstract] [Full Text] [Related]
11. [Present state and perspective of cytokine research].
Takaku F
Hum Cell; 1993 Jun; 6(2):75-81. PubMed ID: 7692952
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy].
Pfreundschuh M
Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398
[No Abstract] [Full Text] [Related]
13. Neurologic complications of cytokine therapy.
Forman AD
Oncology (Williston Park); 1994 Apr; 8(4):105-10; discussion 113, 116-7. PubMed ID: 8003395
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapy of melanoma with cytokines and lymphocytes.
Bear HD; Hamad GG; Kostuchenko PJ
Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
[TBL] [Abstract][Full Text] [Related]
15. Lymphokines and cytokines.
Wagstaff J
Cancer Chemother Biol Response Modif; 1991; 12():165-92. PubMed ID: 1718375
[No Abstract] [Full Text] [Related]
16. [The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer].
Wirth M
Urologe A; 1991 Mar; 30(2):77-80. PubMed ID: 1711729
[TBL] [Abstract][Full Text] [Related]
17. [Recent trends in cancer treatment using cytokines].
Urushizaki I
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):897-905. PubMed ID: 2471455
[TBL] [Abstract][Full Text] [Related]
18. Design of combination biotherapy studies: future goals and challenges.
Gilewski TA; Golomb HM
Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
[TBL] [Abstract][Full Text] [Related]
19. Immunological monitoring and clinical trials of biological response modifiers.
Baseler MW; Urba WJ
Cancer Chemother Biol Response Modif; 1992; 13():205-29. PubMed ID: 1382527
[No Abstract] [Full Text] [Related]
20. The current use of interferons, interleukin-2 and tumor necrosis factor in renal cell cancer.
Wirth M
Urol Int; 1991; 47(4):219-30. PubMed ID: 1723554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
